Maxmorgan Pharma Private Limited
About Maxmorgan Pharma Private Limited
Data last updated:
Maxmorgan Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It was incorporated on 28 November 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U46497DL2023PTC423182.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Sudha Devi and Khushbu Kumari.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E 262, Basement, New Delhi, Delhi, India – 110065.
As per the financials filed for FY 2025, the company reported a revenue of ₹52.22 Lakh. For the same year it recorded a net loss of ₹49,886 (net margin -1%) and EBITDA of -₹29,886 (EBITDA margin -0.6%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressE 262, Basement, New Delhi, Delhi, India – 110065
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Maxmorgan Pharma Private Limited FY 2025 filings available
Maxmorgan Pharma Private Limited reported revenue of ₹52.22 Lakh for FY 2025.
Financial Statement Summary of Maxmorgan Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹29,886 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹49,886 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Maxmorgan Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -0.6% | •••• |
| Net Profit Margin | -1% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Maxmorgan Pharma are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Maxmorgan Pharma Private Limited
Maxmorgan Pharma Private Limited is compared with the companies closest to it by revenue in the Automobiles industry (Auto and Components Dealers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nanavati Vehicles Private Limited | ₹52.84 Lakh (FY 2016) | •••• | •••• | -93.0% | •••• | Surat, Gujarat, India |
| Kuttiattoor Motors Private Limited | ₹52.74 Lakh (FY 2024) | •••• | •••• | 56.0% | •••• | Kannur, Kerala, India |
| Topline Commercial Private Limited | ₹52.63 Lakh (FY 2025) | •••• | •••• | 47.0% | •••• | Kolkata, West Bengal, India |
| Swift Power Solution Private Limited | ₹52.5 Lakh (FY 2025) | •••• | •••• | -25.0% | •••• | New Delhi, Delhi, India |
| Radhe Govind Enterprises Private Limited | ₹52.33 Lakh (FY 2025) | •••• | •••• | -33.0% | •••• | Secunderabad, Telangana, India |
| Maxmorgan Pharma Private Limited this company | ₹52.22 Lakh (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Kabra Rubbers Private Limited | ₹52.16 Lakh (FY 2021) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Pashi Auto Engineers Private Limited | ₹52.12 Lakh (FY 2016) | •••• | •••• | 99.0% | •••• | Chandigarh, India |
| Sri Krishna Automart Private Limited | ₹52.01 Lakh (FY 2025) | •••• | •••• | -79.0% | •••• | Sheikhpura, Bihar, India |
| Falcon Indventure Private Limited | ₹52.01 Lakh (FY 2025) | •••• | •••• | -26.0% | •••• | Patna, Bihar, India |
| Detailing Daddy Private Limited | ₹51.89 Lakh (FY 2023) | •••• | •••• | 2313.0% | •••• | Ranchi, Jharkhand, India |
Peers are the five companies nearest above and the five nearest below Maxmorgan Pharma by revenue in the Automobiles industry (Auto and Components Dealers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Maxmorgan Pharma Private Limited
Maxmorgan Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudha Devi | Director | 28 Nov 2023 | 2 Years 10 Months | Current |
| Khushbu Kumari | Additional Director | 06 Jun 2025 | 1 Years 4 Months | Current |
Charges & Borrowings of Maxmorgan Pharma Private Limited
Maxmorgan Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Maxmorgan Pharma Private Limited
Employment history and EPFO contributions of people linked to Maxmorgan Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Maxmorgan Pharma Private Limited
Maxmorgan Pharma Private Limited has 3 board changes on record since 2023: 2 appointments and 1 cessation. The latest: Ajay Kumar Singh ceased to be Director on 06 Jun 2025.
Credit Ratings, Litigation & Regulatory Alerts for Maxmorgan Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Maxmorgan Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Maxmorgan Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Maxmorgan Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Maxmorgan Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maxmorgan Pharma Private Limited
Maxmorgan Pharma is an active private limited company based in New Delhi, Delhi, India. It was incorporated on 28 November 2023 (3+ years old) and is registered under CIN U46497DL2023PTC423182.
Maxmorgan Pharma reported revenue of ₹52.22 Lakh for FY 2025.
Maxmorgan Pharma has 2 current directors:
- Sudha Devi - Director
- Khushbu Kumari - Additional Director
Maxmorgan Pharma reported a net loss of ₹49,886 (net margin -1%) and EBITDA of -₹29,886 (EBITDA margin -0.6%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Maxmorgan Pharma is U46497DL2023PTC423182. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxmorgan Pharma was incorporated on 28 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Maxmorgan Pharma by revenue are Nanavati Vehicles Private Limited, Kuttiattoor Motors Private Limited, Topline Commercial Private Limited, Swift Power Solution Private Limited, Radhe Govind Enterprises Private Limited and 5 more, all in the Automobiles industry (Auto and Components Dealers).
Ajay Kumar Singh ceased to be Director on 06 Jun 2025. Khushbu Kumari was appointed as Additional Director on 06 Jun 2025. Sudha Devi was appointed as Director on 28 Nov 2023.
The registered office of Maxmorgan Pharma is at E 262, Basement, New Delhi, Delhi, India – 110065.
Maxmorgan Pharma has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh.
No. Maxmorgan Pharma is not listed on any stock exchange. It is an unlisted company.